IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+3.55%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
(-20%)
Cap. Flow
-$46.8M
Cap. Flow
% of AUM
-13.39%
Top 10 Holdings %
Top 10 Hldgs %
42.96%
Holding
198
New
27
Increased
9
Reduced
43
Closed
22
Top Buys
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$11.5M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$7.89M |
| 3 |
CMPS
Compass Pathways
CMPS
|
$6.85M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$6.66M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$6.2M |
Sector Composition
| 1 | Healthcare | 97.67% |
| 2 | Consumer Staples | 0.57% |
| 3 | Technology | 0.35% |
| 4 | Financials | 0.21% |
| 5 | Real Estate | 0.11% |
